Skip to content

Clinical study of perioperative low opioid analgesia strategy to improve postoperative quality of life in elderly patients with thoracoscopic lung cancer

Clinical study of perioperative low opioid analgesia strategy to improve postoperative quality of life in elderly patients with thoracoscopic lung cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086308
Enrollment
Unknown
Registered
2024-06-28
Start date
2024-07-24
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Conventional dose opioid group:Sufentanil was injected intravenously at 0.3 µg/kg during induction. Sufentanil was injected intravenously at 0.15 µg/kg before incision. Sufentanil 0.15 µg/kg was added
Low dose opioid group:During induction, sufentanil 0.15 µg/kg + esketamine 0.15 mg/kg were injected intravenously. Intravenous injection of sufentanil 0.075 µg/kg + esketamine 0.075 mg/kg before incis
PCIA formulation (sufentanil 0.015 µg/kg/h + esketamine 0.015 mg/kg/h + dexamethasone 15 mg + Ondansetron 12 mg) 72 hours after surgery.

Sponsors

Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: The patients were selected to undergo a single or double-orifice unilateral thoracoscopic segmental resection or lobectomy, regardless of gender, aged 65-80 years, BMI 18-30 kg/m2, and ASA grade I-III

Exclusion criteria

Exclusion criteria: 1) contraindicated thoracic paravertebral block; 2) Serious heart, lung, liver and kidney diseases; 3) Patients with severe hypertension, glaucoma or elevated intracranial pressure, untreated or undertreated hyperthyroidism; 4) Chronic pain, alcoholism, psychosis and opioid dependence; 5) Mental illness or communication disorder; 6) Severe sleep and cognitive disorders, Athens Insomnia Scale (AIS) score =6, Mini-Mental Status Examination (MMSE) score =27 after admission; 7) People who are allergic to or addicted to esketamine active ingredients and excipients; 8) Patients who refused to participate in this study; 9) Transfer to open surgery

Design outcomes

Primary

MeasureTime frame
Quality scores were recovered 24 h, 48 h, 72 h after surgery;Incidence of chronic pain and pain intensity 3 months after surgery;Nightmares;

Secondary

MeasureTime frame
Resting and dynamic pain VAS scores 24 h, 48 h, 72 h after surgery;Ramsay sedation scores 24 h, 48 h, 72 h after surgery;The incidence and intensity of chronic pain and neuropathic pain 6 months after surgery;Assens Insomnia Scale (AIS) score 24 h, 48 h, 72 h after surgery;

Countries

China

Contacts

Public ContactQun Fu

Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University

qunfunju@163.com+86 199 5194 7123

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026